EXOMIND (BTL-699-2) for Improvement of Mental Well-being

Clinical trial NCT06899646 · COMPLETED

Trial details

NCT number: NCT06899646
Sponsor: BTL Industries Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Well-Being, Psychological

Start date: 2024-07-08
Primary completion: 2025-02-03
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.